EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
Zurück zu den Kollektionen

Cyberkriminalität, Erpresser fordern nach Angriff auf Ozempic-Hersteller Novo Nordisk 25 Millionen Dollar, Archivbilder

17.06.2026

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

  • Opening of a new plant for the production of next-generation diabetes and obesity medications by the Danish pharmaceutical company Novo Nordisk, on June 12, 2026, Jevany near Prague, Czech Republic. (CTKxPhoto VitxSimanek) CTKPhotoP2026061203139 CTKPhotoP2026061203139
  • Opening of a new plant for the production of next-generation diabetes and obesity medications by the Danish pharmaceutical company Novo Nordisk, on June 12, 2026, Jevany near Prague, Czech Republic. (CTKxPhoto VitxSimanek) CTKPhotoP2026061203041 CTKPhotoP2026061203041
  • Novo Nordisk President Mike Doustdar poses to photographer during the opening of a new plant for the production of next-generation diabetes and obesity medications by the Danish pharmaceutical company Novo Nordisk, on June 12, 2026, Jevany near Prague, Czech Republic. (CTKxPhoto VitxSimanek) CTKPhotoP2026061203038 CTKPhotoP2026061203038
  • February 27, 2026, Germany: In this photo illustration, Danish pharmaceutical company Novo Nordisk AS logo is seen displayed on a smartphone in front of an abstract background on a computer screen. Germany - ZUMAs197 20260227_aab_s197_102 Copyright: xTimonxSchneiderx
  • NOVO NORDISK MIKE DOUSTDAR, Novo Nordisk CEO Mike Doustdar is seen at Parliament House in Canberra, Monday, March 16, 2026. ( NO ARCHIVING CANBERRA AUSTRALIAN CAPITAL TERRITORY AUSTRALIA Copyright: xMICKxTSIKASx 20260316190313278138
  • Die Aktienkurse und Finanzdaten von Novo Nordisk werden auf einer mobilen App Oberfläche angezeigt Novo Nordisk stock prices and financial data shown on a mobile app interface Copyright: imageBROKER MdxMamunxMiah iblmia16812518.jpg
  • Das Novo Nordisk-Logo erscheint auf dem Bildschirm mit einer medizinischen Spritze in dieser Fotoillustration in Ontario, Kanada, am 3. Februar 2026. The Novo Nordisk logo appears on the screen with a medical syringe in this photo illustration in Ontario, Canada, on February 3, 2026 (License=RM) Copyright: xZoonar.com RafaelxHenriquexdaxSilvax 24626598
  • Insulinspritze von Novo Nordisk Symbolbild Detailaufnahme einer wiederbefüllbaren Insulinspritze des Pharmaunternehmens Novo Nordisk zur Verabreichung von Insulin bei Diabetes. Symbolbild. Bonn Nordrhein-Westfalen Deutschland *** Insulin syringe from Novo Nordisk Symbolic image Close-up of a refillable insulin syringe from the pharmaceutical company Novo Nordisk for the administration of insulin in diabetes Symbolic image Bonn North Rhine-Westphalia Germany Copyright: xMarcxJohnx
  • Insulinspritze von Novo Nordisk Symbolbild Detailaufnahme einer wiederbefüllbaren Insulinspritze des Pharmaunternehmens Novo Nordisk zur Verabreichung von Insulin bei Diabetes. Symbolbild. Bonn Nordrhein-Westfalen Deutschland *** Insulin syringe from Novo Nordisk Symbolic image Close-up of a refillable insulin syringe from the pharmaceutical company Novo Nordisk for the administration of insulin in diabetes Symbolic image Bonn North Rhine-Westphalia Germany Copyright: xMarcxJohnx
  • Denmark Novo Nordisk comments on annual report Novo Nordisk s CEO Mike Doustdar comments on the company s annual report at the headquarters in Bagsvaerd on Wednesday, January 4, 2026. (Photo: Thomas Traasdahl Ritzau Scanpix) , Copenhagen Denmark *** Denmark Novo Nordisk comments on annual report Novo Nordisk s CEO Mike Doustdar comments on the company s annual report at the headquarters in Bagsvaerd on Wednesday, January 4, 2026 Photo Thomas Traasdahl Ritzau Scanpix , Copenhagen Denmark Copyright: RitzauxScanpix ThomasxTraasdahlx spdk20260204-134731-L
  • Bagsvaerd openhagen DenmarK 18 JANUARY 2026 Novo nordisk pharmaceuticl company in bagsvaerd in copenhagen denmark.(Photo.Francis Joeph Dean Dean Pictures)Not for commercial use.
  • Novo Nordisk A S Headquarters In Bagsvaerd Flags with the logo of the pharmaceutical company Novo Nordisk flutter in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on December 23, 2025. Bagsvaerd Denmark Copyright: xKristianxTuxenxLadegaardxBergx originalFilename: berg-novonord251223_npHUw.jpg
  • Novo Nordisk A S Headquarters In Bagsvaerd The logo of the pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on December 23, 2025. Bagsvaerd Denmark Copyright: xKristianxTuxenxLadegaardxBergx originalFilename: berg-novonord251223_npIvr.jpg
  • November 6, 2025, Washington, District Of Columbia, USA: Mike Doustdar, chief executive officer of Novo Nordisk A S, in the Oval Office of the White House in Washington, DC, US, on Thursday, Nov. 6, 2025. Eli Lilly & Co. and Novo Nordisk A S secured deals with the Trump administration to slash prices for their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients Washington USA - ZUMAs152 20251106_faa_s152_028 Copyright: xAaronxSchwartzx-xPoolxviaxCNPx
  • Illustration Novo Nordisk CHONGQING, CHINA - SEPTEMBER 10, 2025 - An illustration photo shows the Novo Nordisk logo in a smartphone in Chongqing, China on September 10, 2025. Chongqing Chongqing China Copyright: xCFOTOx i1757544984427
  • Novo s new CEO, Mike Doustdar New CEO, Executive Vice President, International Operations Mike Doustdar at Novo Nordisk in Bagsvaerd on Thursday, August 7, 2025. Novo Nordisk announced on July 29 that Maziar Mike Doustdar will take over as the company s CEO. He has worked for Novo Nordisk for 33 years in various roles and lives in Switzerland. This is the first time Novo Nordisk will not have a new Danish top executive, as Doustdar is an Iranian-born Austrian citizen.. (Photo: Mads Claus Rasmussen Ritzau Scanpix) , Bagsvaerd Denmark *** Novo s new CEO, Mike Doustdar New CEO, Executive Vice President, International Operations Mike Doustdar at Novo Nordisk in Bagsvaerd on Thursday, August 7, 2025 Novo Nordisk announced on July 29 that Mazia Copyright: RitzauxScanpix MadsxClausxRasmussenx spdk20250807-112634-L
  • A package of Ozempic injection solution and injection pen with four needles photographed in Malmö, Sweden, February 2025. Ozempic is manufactured by the Danish company Novo Nordisk and contains Semaglutide, which provides significant weight loss. MALMÖ SWEDEN x50090x *** A package of Ozempic injection solution and injection pen with four needles photographed in Malmö, Sweden, February 2025 Ozempic is manufactured by the Danish company Novo Nordisk and contains Semaglutide, which provides significant weight loss MALMÖ SWEDEN x50090x Copyright: xJohanxNilssonx xTTx OZEMPIC INJECTION PEN 3paQGDU8tJ8
  • (ARKIV) Novo Nordisk i Kalundborg, den 8. april 2005. Den amerikanske laegemiddelstyrelse, FDA, har godkendt Novo Nordisks diabetespille, oral semaglutid. Det skriver Bloomberg News ifoelge Ritzau Finans. . , Kalundborg Sjaelland Denmark *** ARCHIVE Novo Nordisk in Kalundborg, April 8, 2005 The US Medicines Agency (FDA) has approved Novo Nordisks diabetes pill, oral semaglutide., Copyright: JensxNoergaardxLarsenx COP444 spdk20190920-164710-L
  • (ARKIV) Novo Nordisk. Den amerikanske laegemiddelstyrelse, FDA, har godkendt Novo Nordisks diabetespille, oral semaglutid. Det skriver Bloomberg News ifoelge Ritzau Finans. Det skriver Ritzau, fredag den 20. september 2019.. , Bagsvaerd Hovedstaden Denmark *** ARCHIVE Novo Nordisk The US Medicines Agency (FDA) has approved Novo Nordisks diabetes pill, oral semaglutide Bloomberg News according to Ritzau Finance It writes Ritzau, Friday, September 20, 2019, Bagsvaerd Capital Denmark, Copyright: JensxNoergaardxLarsenx COP444 spdk20190920-164600-A